Burning Rock Biotech Limi... (BNR)
NASDAQ: BNR
· Real-Time Price · USD
7.57
0.62 (8.92%)
At close: Aug 15, 2025, 11:58 AM
Burning Rock Biotech Cash Flow Statement
Financials in CNY. Fiscal
year is
January - December.
| Fiscal Year | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | n/a | n/a | n/a | -121.55M | -162.21M | -174.98M | -131.24M | -185.25M | -709.85M | -226.31M | -262.14M | -261.39M | -251.14M | -170.48M | -203.66M | -171.41M |
Depreciation & Amortization | n/a | n/a | n/a | n/a | 131.45M | n/a | n/a | n/a | 124.1M | n/a | n/a | n/a | 47.77M | n/a | 21.65M | n/a |
Stock-Based Compensation | n/a | n/a | n/a | 69.38M | 71.34M | 73.39M | 37.82M | 78.17M | 326.78M | 77.85M | 77.14M | 80.15M | 282.43M | 53.55M | 83.41M | 84.76M |
Other Working Capital | n/a | n/a | n/a | n/a | -45.24M | n/a | n/a | n/a | -6.33M | n/a | n/a | n/a | 21.41M | n/a | -32.79M | n/a |
Other Non-Cash Items | 19.06M | -30.28M | -40.84M | 11.96M | 74.85M | 54.17M | 14.22M | -6.06M | 184.93M | 13M | 75.73M | 117.03M | -191.4M | 37.08M | 84.67M | 58.27M |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 21.41M | n/a | n/a | n/a |
Change in Working Capital | -41.92M | n/a | n/a | n/a | -4.36M | n/a | n/a | n/a | 6.33M | n/a | n/a | n/a | -21.41M | n/a | -100.72M | n/a |
Operating Cash Flow | 19.06M | -30.28M | -40.84M | -40.21M | -16.02M | -47.42M | -79.2M | -113.14M | -67.71M | -135.47M | -109.27M | -144.36M | -112.35M | -133.39M | -119M | -113.14M |
Capital Expenditures | -5.42M | n/a | n/a | n/a | -8.1M | n/a | n/a | n/a | -62.03M | n/a | n/a | n/a | -204.33M | n/a | -104.82M | n/a |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -90.25M | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -63.92M | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 65.6M | n/a | n/a | n/a | 358.5M | n/a | n/a | n/a |
Other Investing Acitivies | -812K | -987K | -227K | -2.39M | -328K | -1.99M | -2.93M | -4.06M | -8.6M | -20.15M | 30.73M | -13.01M | -66.97M | -72.08M | -67.58M | 288.33M |
Investing Cash Flow | -812K | -987K | -227K | -2.39M | -328K | -1.99M | -2.93M | -4.06M | -5.03M | -20.15M | 30.73M | -13.01M | -66.97M | -72.08M | -67.58M | 288.33M |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | -6.98M | n/a | n/a | n/a | -71.83M | n/a | n/a | n/a | -4.27M | n/a | -4.27M | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -74K | 2K | n/a | n/a | -1.91M | -45.89M | -1M | -32K | -10.07M | -2.67M | -69.56M | -3.93M | -6.78M | -32.99M | -8.96M | -4.16M |
Financial Cash Flow | -74K | 2K | n/a | n/a | -1.91M | -45.89M | -1M | -32K | -10.07M | -2.67M | -69.56M | -3.93M | -6.78M | -32.99M | -8.96M | -4.16M |
Net Cash Flow | 23.91M | -34.8M | -39.63M | -42.54M | -21.53M | -96.53M | -69.86M | -122.13M | -88.74M | -139.04M | -121.83M | -164.24M | -210.6M | -233.56M | -229.62M | 187.68M |
Free Cash Flow | 13.09M | -30.28M | -40.84M | -40.21M | -24.12M | -47.42M | -79.2M | -113.14M | -129.74M | -135.47M | -109.27M | -144.36M | -316.68M | -133.39M | -223.82M | -113.14M |